Industry Briefs: Mar. 26, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Corcept Therapeutics has selected PharmaForm as its primary commercial manufacturer for its newly approved drug product, Korlym (mifepristone) for treating Cushing’s syndrome.
Coronado Biosciences has signed a collaboration agreement with Dr. Falk Pharma and OvaMed for the development of trichuris suis ova for treating Crohn’s Disease.
Elite Pharmaceuticals has signed an agreement with a private Hong Kong-based company to develop a branded prescription pharmaceutical product in the US.
GE Healthcare has expanded its Shanghai Fast Trak training center to serve the growing biopharmaceutical industry in China.
Impax and Tolmar have multiproduct agreement for the development, supply, and distribution of alternative dosage-form products.
Marken has completed all commissioning work for its new operational hub in Feltham, United Kingdom.
People News
Adhesives Research appointed Steven Herbert to the position of manufacturing manager.
Albany Molecular Research has named Stephen Rossmeis senior manager to oversee the company's facilities at Burlington, Massachusetts aseptic-fill operations.
Avrio Biopharmaceuticals has appointed William P. Botha as president.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
